Medicare Enrolled

Dr. William Bensinger, MD

Internal Medicine · Lakewood, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
11311 BRIDGEPORT WAY SW STE 302, Lakewood, WA 98499
2535336700
In practice since 2006 (19 years)
NPI: 1922198886 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bensinger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bensinger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bensinger

Dr. William Bensinger is an internal medicine specialist in Lakewood, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bensinger performed 296 Medicare services across 111 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bensinger received a total of $1,474,069 from 24 pharmaceutical and/or device companies across 1221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bensinger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 296 Medicare services $1,474,069 industry payments

Medicare Practice Summary

Medicare Utilization ↗
296
Medicare services
Bottom 37% in WA for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
111
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
148 $0 $2
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
38 $12 $52
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
34 $11 $52
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
33 $105 $322
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
25 $49 $150
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
18 $22 $75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
25.7% high complexity
74.3% medium
0.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,474,069
Total received (2018-2024)
Avg $210,581/year across 7 years
Top 0% in WA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
1,221
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,414,003 (95.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$47,786 (3.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,280 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$238,917
2023
$142,292
2022
$256,068
2021
$141,028
2020
$83,294
2019
$272,174
2018
$340,294

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$90,055
GENZYME CORPORATION
$79,886
AstraZeneca Pharmaceuticals LP
$46,403
Amgen Inc.
$22,343
Janssen Scientific Affairs, LLC
$113
Janssen Biotech, Inc.
$55
Daiichi Sankyo Inc.
$25
Celgene Corporation
$20
Merck Sharp & Dohme LLC
$18
Top 3 companies account for 90.6% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$258,561
Amgen Inc.
$238,363
Janssen Biotech, Inc.
$215,233
Takeda Pharmaceuticals U.S.A., Inc.
$187,602
Celgene Corporation
$140,266
AstraZeneca Pharmaceuticals LP
$101,715
E.R. Squibb & Sons, L.L.C.
$101,050
Janssen Scientific Affairs, LLC
$100,342
PFIZER INC.
$93,811
Incyte Corporation
$12,039
GlaxoSmithKline, LLC.
$9,221
Genentech, Inc.
$8,029
Regeneron Pharmaceuticals, Inc.
$5,895
Secura Bio, Inc.
$1,500
Pharmacyclics LLC, An AbbVie Company
$141
EUSA Pharma (US) LLC
$127
SANOFI-AVENTIS U.S. LLC
$33
Seagen Inc.
$27
Daiichi Sankyo Inc.
$25
CTI BioPharma Corp.
$22
Astellas Pharma US Inc
$20
Merck Sharp & Dohme LLC
$18
Coherus Biosciences Inc.
$15
Rigel Pharmaceuticals, Inc.
$12
Top 3 companies account for 48.3% of all-time payments
Associated products mentioned in payments ›
ABECMA · BESPONSA · BLENREP · Blincyto · CALQUENCE · CD38 · DARZALEX · ELITEK · ELREXFIO · EMPLICITI · FARYDAK · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · JEMPERLI · KEYTRUDA · Kyprolis · Lunsumio · NINLARO · NO PRODUCT DISCUSSED · PADCEV · Padcev · Pomalyst · Revlimid · SARCLISA · Sylvant · TAGRISSO · TECVAYLI · Tavalisse · Udenyca · Vanflyta · Venclexta · Vonjo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in WA.

Looking for an internal medicine specialist in Lakewood?
Compare internal medicine physicians in the Lakewood area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
661
Per 100K population
71.5
County median income
$96,632
Nearest hospital
ST CLARE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bensinger is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bensinger experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Bensinger performed 148 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bensinger receive payments from pharmaceutical companies?
Yes. Dr. Bensinger received a total of $1,474,069 from 24 companies across 1,221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bensinger's costs compare to other internal medicine physicians in Lakewood?
Dr. Bensinger's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bensinger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →